M&A Deal Summary |
|
|---|---|
| Date | 2016-11-28 |
| Target | Accucaps Industries |
| Sector | Medical Products |
| Buyer(s) | Catalent |
| Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 2007 |
| Sector | Life Science |
| Revenue | 4.3B USD (2023) |
Catalent is a provider of solutions for drugs, biologics and consumer health products. Among its core offerings, it develops and manufactures oral and sterile medication in nearly all dosage forms, holds patents for softgel (e.g. “Liqui-Caps” and “Vegicaps”) and Zydis fast-dissolve technologies used in many popular prescription and over-the-counter medicine. Catalent was founded in 2007 and is based in Somerset, New Jersey.
| DEAL STATS | # |
|---|---|
| Overall | 5 of 16 |
| Sector (Medical Products) | 2 of 3 |
| Type (Add-on Acquisition) | 5 of 10 |
| State (Ontario) | 1 of 1 |
| Country (Canada) | 1 of 1 |
| Year (2016) | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-09-13 |
Pharmatek Laboratories
San Diego, California, United States Pharmatek Laboratories, Inc. is a manufacturer of oral, injectable and topical products for more than 100 customers globally. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-09-19 |
Cook Group
Bloomington, Indiana, United States Cook Group, Inc. (Cook Pharmica LLC) is a biologics-focused contract development and manufacturing organization with capabilities across biologics development, clinical and commercial cell culture manufacturing, formulation, finished-dose manufacturing, and packaging. Cook Pharmica LLC was established in 2004 and is based in Bloomington, Indiana. |
Buy | $950M |
